TG Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +2,900.0% | -60.0% | +346.6% | -49.4% | -81.6% | – | – | – | – | – | – | – | – | – | – | +700.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.3% | +0.0% | +0.0% | +4,300.7% | -58.4% | +8,290.0% | +40.8% | +87.3% | |
| – | – | – | – | +407.4% | -48.7% | – | – | – | – | – | – | – | – | – | – | – | – | +174.9% | +13.3% | +24.9% | +50.2% | -99.9% | +220.5% | +32.6% | +111.2% | -66.5% | +5,232.5% | +172.4% | +161.7% | |
| – | +100.0% | +1,500.0% | -87.5% | +224.9% | -51.6% | -20.6% | – | – | – | – | – | – | – | – | – | – | +700.0% | +0.0% | +0.0% | +0.0% | +0.0% | -58.0% | +137.5% | +0.0% | +3,780.9% | -57.3% | +8,611.5% | +32.3% | +77.5% | |
| – | +136.4% | +15.4% | -63.3% | +2.8% | -21.6% | -39.1% | +219.4% | +140.9% | +310.9% | -63.8% | +38.3% | -78.9% | -97.8% | +1,127.9% | -34.0% | +6,185.7% | -38.6% | +148.4% | +38.6% | +53.0% | +45.7% | +58.7% | +0.3% | +7.6% | +34.2% | -43.7% | -39.2% | +23.8% | +69.9% | |
| – | – | – | – | – | – | – | +18.0% | +11.4% | +15.1% | +67.1% | -5.7% | -27.7% | -33.7% | -12.1% | +30,683.4% | -99.0% | +39.2% | +137.1% | -1.0% | -19.2% | +74.0% | -31.0% | -0.9% | +617.7% | +18.8% | -25.5% | +28.5% | +25.7% | +50.4% | |
| – | +41.0% | +7.3% | -47.5% | +43.9% | -16.3% | -45.1% | +131.8% | +29.1% | +215.1% | -48.3% | +21.4% | -63.7% | -59.9% | +13.8% | -56.3% | +2,826.3% | -21.3% | +175.0% | +13.3% | +24.9% | +50.2% | +46.9% | -3.1% | +61.8% | +28.1% | -37.0% | -9.9% | +25.0% | +57.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +103.2% | +194.1% | |
| – | – | – | – | – | – | – | – | – | – | – | -71.4% | +13,511.3% | +746.4% | +131.8% | -99.4% | +12,662.4% | +5.2% | -2.3% | +4.5% | -100.0% | – | +52.2% | +204.9% | +19.7% | -10.9% | +80.8% | +23.8% | +90.5% | +11.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -166.0% | – | – | – | – | – | – | – | – | – | – | – | – | +95.9% | +319.6% | |
| – | – | +0.0% | -400.0% | – | -152.0% | – | – | -120.5% | – | – | – | – | – | -358.4% | – | – | -853.9% | – | -484.4% | – | – | – | – | +0.3% | +14.7% | -26.2% | -92.9% | +466.9% | -15,468.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -236.8% | – | – | – | – | – | – | – | – | – | – | – | – | +84.5% | +1,812.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -144.6% | – | – | – | – | – | – | – | – | – | – | – | – | +91.2% | +169.2% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.